Wingate Wealth Advisors, Inc. Amarin Corp Plcuk Transaction History
Wingate Wealth Advisors, Inc.
- $102 Billion
- Q4 2024
A detailed history of Wingate Wealth Advisors, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Wingate Wealth Advisors, Inc. holds 485 shares of AMRN stock, worth $271. This represents 0.0% of its overall portfolio holdings.
Number of Shares
485Holding current value
$271% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRN
# of Institutions
178Shares Held
64.4MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$13.9 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$6.95 Million0.64% of portfolio
-
Eversept Partners, LP New York, NY3.31MShares$1.85 Million0.16% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.43 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.4 Million1.16% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $226M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...